Olesoxime
Olesoxime (TRO 19622) is a mitochondrial-targeted neuroprotective compound with mean EC50 value for increasing cell survival is 3.2±0.2 μM.
Product Specifications
CAS Number
22033-87-0
Product Name Alternative
TRO 19622; NSC 21311
UNSPSC
12352211
Hazard Statement
H302, H315, H319, H335
Target
Mitochondrial Metabolism
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/TRO-19622.html
Purity
99.09
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
C[C@@]12C(CC[C@]3([H])[C@]2([H])CC[C@@]4(C)[C@@]3([H])CC[C@@]4([C@]([H])(C)CCCC(C)C)[H])=CC(CC1)=NO
Molecular Formula
C27H45NO
Molecular Weight
399.65
Precautions
H302, H315, H319, H335
References & Citations
[1]Martin LJ, et al. Olesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosis. IDrugs. 2010 Aug;13 (8) :568-80.|[2]Bordet T, et al. Olesoxime (TRO19622) : A Novel Mitochondrial-Targeted Neuroprotective Compound. Pharmaceuticals (Basel) . 2010 Jan 28;3 (2) :345-368|[3]Bordet T, et al. Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis. J Pharmacol Exp Ther. 2007 Aug;322 (2) :709-20.|[4]Xiao WH, et al. Olesoxime (cholest-4-en-3-one, oxime) : analgesic and neuroprotective effects in a rat model of painful peripheral neuropathy produced by the chemotherapeutic agent, paclitaxel. Pain. 2009 Dec 15;147 (1-3) :202-9
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
19193121 3x 1.0µg DNA
ELAC2 CRISPRa sgRNA lentivector (set of three targets)(Human)
Sign In for Pricing
View Details 
